Revolution Medicines EBITDA 2018-2025 | RVMD

Revolution Medicines EBITDA for the quarter ending March 31, 2025 was $-0.247B, a 60.99% increase year-over-year.

  • Revolution Medicines 2024 EBITDA was -0.722B, a 44.43% increase from 2023.
  • Revolution Medicines 2023 EBITDA was -0.5B, a 98.68% increase from 2022.
  • Revolution Medicines 2022 EBITDA was -0.252B, a 41.67% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Revolution Medicines EBITDA 2018-2025 | RVMD

  • Revolution Medicines 2024 EBITDA was -0.722B, a 44.43% increase from 2023.
  • Revolution Medicines 2023 EBITDA was -0.5B, a 98.68% increase from 2022.
  • Revolution Medicines 2022 EBITDA was -0.252B, a 41.67% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.